Clinical Outcomes of Pars Plana Vitrectomy for Persistent Vitreous Opacities in Infectious and Noninfectious Uveitis.

IF 1.1 4区 医学 Q4 OPHTHALMOLOGY
Ludovico Alisi, Marta Armentano, Giacomo Visioli, Massimo Accorinti, Elvia Mastrogiuseppe, Mattia D'Andrea, Giulia Firmani, Maria Pia Pirraglia, Magda Gharbiya, Ludovico Iannetti
{"title":"Clinical Outcomes of Pars Plana Vitrectomy for Persistent Vitreous Opacities in Infectious and Noninfectious Uveitis.","authors":"Ludovico Alisi, Marta Armentano, Giacomo Visioli, Massimo Accorinti, Elvia Mastrogiuseppe, Mattia D'Andrea, Giulia Firmani, Maria Pia Pirraglia, Magda Gharbiya, Ludovico Iannetti","doi":"10.3928/23258160-20250718-01","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>This study evaluated functional and inflammatory outcomes after pars plana vitrectomy (PPV) in patients with persistent vitreous opacities due to infectious and noninfectious uveitis unresponsive to medical therapy.</p><p><strong>Patients and methods: </strong>Twenty-three eyes with noninfectious uveitis and 16 eyes with infectious uveitis were enrolled. Functional and inflammatory parameters were assessed, focusing on best-corrected visual acuity (BCVA), vitreous haze, and inflammation.</p><p><strong>Results: </strong>At 6 months, both vitreous haze and anterior chamber inflammation decreased from severe to minimal levels. BCVA improved in 28 eyes (71.8%), remained stable in five eyes (12.8%), and worsened in six eyes (15.4%). Linear regression analysis showed that preoperative BCVA significantly predicted visual improvement (coefficient = 0.60, 95% confidence interval [CI]: 0.22-0.98, <i>P</i> = 0.003), while etiology (<i>P</i> = 0.217) and lens status (<i>P</i> = 0.201) were not significant factors (R<sup>2</sup> = 0.34). Elevated intraocular pressure occurred in five patients, with two requiring trabeculectomy after 3 months. In two cases, epiretinal membrane formation progressed to tractional retinal detachment within 6 months.</p><p><strong>Conclusion: </strong>PPV is an effective treatment for persistent vitreous opacities, resulting in visual improvement and stabilization of inflammation. Postoperative follow-up is necessary due to potential complications and recurrence.</p>","PeriodicalId":19679,"journal":{"name":"Ophthalmic surgery, lasers & imaging retina","volume":" ","pages":"1-8"},"PeriodicalIF":1.1000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic surgery, lasers & imaging retina","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/23258160-20250718-01","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: This study evaluated functional and inflammatory outcomes after pars plana vitrectomy (PPV) in patients with persistent vitreous opacities due to infectious and noninfectious uveitis unresponsive to medical therapy.

Patients and methods: Twenty-three eyes with noninfectious uveitis and 16 eyes with infectious uveitis were enrolled. Functional and inflammatory parameters were assessed, focusing on best-corrected visual acuity (BCVA), vitreous haze, and inflammation.

Results: At 6 months, both vitreous haze and anterior chamber inflammation decreased from severe to minimal levels. BCVA improved in 28 eyes (71.8%), remained stable in five eyes (12.8%), and worsened in six eyes (15.4%). Linear regression analysis showed that preoperative BCVA significantly predicted visual improvement (coefficient = 0.60, 95% confidence interval [CI]: 0.22-0.98, P = 0.003), while etiology (P = 0.217) and lens status (P = 0.201) were not significant factors (R2 = 0.34). Elevated intraocular pressure occurred in five patients, with two requiring trabeculectomy after 3 months. In two cases, epiretinal membrane formation progressed to tractional retinal detachment within 6 months.

Conclusion: PPV is an effective treatment for persistent vitreous opacities, resulting in visual improvement and stabilization of inflammation. Postoperative follow-up is necessary due to potential complications and recurrence.

感染性和非感染性葡萄膜炎持续性玻璃体混浊的玻璃体切除术的临床效果。
背景和目的:本研究评估了感染性和非感染性葡萄膜炎对药物治疗无反应的持续性玻璃体混浊患者行玻璃体切除术(PPV)后的功能和炎症结果。患者与方法:非感染性葡萄膜炎患者23只眼,感染性葡萄膜炎患者16只眼。评估功能和炎症参数,重点是最佳矫正视力(BCVA)、玻璃体浑浊和炎症。结果:6个月时,玻璃体浑浊和前房炎症均由严重减轻到轻微。BCVA改善28眼(71.8%),稳定5眼(12.8%),恶化6眼(15.4%)。线性回归分析显示术前BCVA可显著预测视力改善(系数= 0.60,95%可信区间[CI]: 0.22-0.98, P = 0.003),而病因(P = 0.217)和晶状体状态(P = 0.201)不是显著因素(R2 = 0.34)。5例患者出现眼压升高,其中2例在3个月后需要小梁切除术。2例视网膜前膜形成在6个月内发展为牵引性视网膜脱离。结论:PPV是治疗持续性玻璃体混浊的有效方法,可改善视力,稳定炎症。由于可能出现并发症和复发,术后随访是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
89
期刊介绍: OSLI Retina focuses exclusively on retinal diseases, surgery and pharmacotherapy. OSLI Retina will offer an expedited submission to publication effort of peer-reviewed clinical science and case report articles. The front of the journal offers practical clinical and practice management features and columns specific to retina specialists. In sum, readers will find important peer-reviewed retina articles and the latest findings in techniques and science, as well as informative business and practice management features in one journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信